Sagittarius Life Science Corp.(TW:3205)
NT$44.80+0.05 (+0.11%)
TW:3205
Sagittarius Life Science Corp. financials statements
NT$44.80
At close:+0.05 (+0.11%)
Sagittarius Life Science Corp. (3205) Ratios
Sagittarius Life Science Corp. Ratios
TW:3205's free cash flow for Q2 2026 was NT$-172.40M. For the 2026 fiscal year, TW:3205's free cash flow was decreased by NT$-50.87M and operating cash flow was NT$-121.53M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 31.84 | 2.73 | 2.62 | 3.22 | 3.56 |
| Quick Ratio | 31.50 | 2.39 | 2.37 | 2.98 | 3.33 |
| Cash Ratio | 5.83 | 0.91 | 1.05 | 1.63 | 2.03 |
| Solvency Ratio | -1.46 | -0.34 | -0.29 | -0.43 | -0.43 |
| Operating Cash Flow Ratio | -1.39 | -0.48 | -0.55 | -0.45 | -0.23 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | NT$ 800.54M | NT$ 150.76M | NT$ 195.04M | NT$ 250.91M | NT$ 304.12M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.02 | 0.02 | 0.02 | 0.04 |
| Debt-to-Equity Ratio | 0.00 | 0.03 | 0.03 | 0.03 | 0.05 |
| Debt-to-Capital Ratio | 0.00 | 0.03 | 0.03 | 0.03 | 0.04 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.03 | 1.27 | 1.29 | 1.31 | 1.31 |
| Debt Service Coverage Ratio | -708.28 | -167.71 | -508.67 | -236.71 | -167.22 |
| Interest Coverage Ratio | -860.40 | -297.40 | -785.07 | -325.92 | -224.41 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.01 | 0.34 | 0.41 | 0.36 | 0.75 |
| Net Debt to EBITDA | 3.14 | 2.10 | 2.89 | 3.21 | 3.51 |
| Profitability Margins | |||||
| Gross Profit Margin | 16.68% | 17.34% | 16.23% | 15.61% | 17.11% |
| EBIT Margin | -16.91% | -10.58% | -12.88% | -14.42% | -14.82% |
| EBITDA Margin | -13.92% | -7.42% | -9.47% | -10.47% | -11.22% |
| Operating Profit Margin | -16.91% | -13.16% | -14.62% | -14.42% | -14.82% |
| Pretax Profit Margin | -14.41% | -10.62% | -12.90% | -14.46% | -14.88% |
| Net Profit Margin | -14.32% | -10.38% | -12.50% | -14.02% | -14.71% |
| Continuous Operations Profit Margin | -14.41% | -10.62% | -12.90% | -14.46% | -14.88% |
| Net Income Per EBT | 99.37% | 97.69% | 96.86% | 96.99% | 98.81% |
| EBT Per EBIT | 85.25% | 80.70% | 88.27% | 100.31% | 100.45% |
| Return on Assets (ROA) | -4.62% | -9.34% | -8.28% | -12.81% | -12.79% |
| Return on Equity (ROE) | -4.76% | -11.88% | -10.69% | -16.80% | -16.72% |
| Return on Capital Employed (ROCE) | -5.59% | -14.39% | -11.97% | -16.48% | -15.84% |
| Return on Invested Capital (ROIC) | -5.59% | -14.17% | -11.82% | -16.20% | -15.35% |
| Return on Tangible Assets | -4.62% | -9.34% | -8.28% | -12.81% | -12.79% |
| Earnings Yield | -1.79% | -4.66% | -3.38% | -5.60% | -9.66% |
| Efficiency Ratios | |||||
| Receivables Turnover | 29.40 | 8.99 | 8.75 | 11.22 | 10.95 |
| Payables Turnover | 45.99 | 6.33 | 5.67 | 5.69 | 5.82 |
| Inventory Turnover | 32.12 | 12.45 | 11.70 | 15.98 | 17.05 |
| Fixed Asset Turnover | 3.81 | 4.27 | 3.94 | 4.68 | 4.56 |
| Asset Turnover | 0.32 | 0.90 | 0.66 | 0.91 | 0.87 |
| Working Capital Turnover Ratio | 0.72 | 2.57 | 1.90 | 1.82 | 1.67 |
| Cash Conversion Cycle | 15.84 | 12.21 | 8.55 | -8.76 | -7.94 |
| Days of Sales Outstanding | 12.41 | 40.58 | 41.73 | 32.52 | 33.35 |
| Days of Inventory Outstanding | 11.36 | 29.31 | 31.20 | 22.84 | 21.41 |
| Days of Payables Outstanding | 7.94 | 57.69 | 64.38 | 64.12 | 62.70 |
| Operating Cycle | 23.78 | 69.90 | 72.93 | 55.36 | 54.76 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.67 | -1.36 | -2.13 | -1.63 | -0.90 |
| Free Cash Flow Per Share | -0.68 | -1.48 | -2.19 | -1.66 | -1.16 |
| Dividend Paid and CapEx Coverage Ratio | -89.22 | -11.70 | -34.46 | -48.39 | -3.46 |
| Capital Expenditure Coverage Ratio | -89.22 | -11.70 | -34.46 | -48.39 | -3.46 |
| Operating Cash Flow Coverage Ratio | -93.63 | -4.13 | -5.21 | -4.65 | -1.22 |
| Operating Cash Flow to Sales Ratio | -0.10 | -0.10 | -0.16 | -0.10 | -0.05 |
| Free Cash Flow Yield | -1.32% | -4.63% | -4.39% | -4.08% | -4.20% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -55.76 | -21.44 | -29.59 | -17.85 | -10.34 |
| Price-to-Sales (P/S) Ratio | 7.99 | 2.23 | 3.69 | 2.50 | 1.52 |
| Price-to-Book (P/B) Ratio | 2.65 | 2.55 | 3.16 | 3.00 | 1.73 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -75.82 | -21.58 | -22.80 | -24.54 | -23.80 |
| Price-to-Operating Cash Flow Ratio | -76.67 | -23.43 | -23.46 | -25.04 | -30.67 |
| Price-to-Earnings Growth (PEG) Ratio | 1.46 | 1.81 | 1.14 | 1.25 | -0.60 |
| Enterprise Value Multiple | -54.24 | -27.91 | -36.12 | -20.69 | -10.06 |
| Enterprise Value | 2.61B | 969.11M | 1.51B | 1.15B | 663.36M |
| EV to EBITDA | -54.24 | -27.91 | -36.12 | -20.69 | -10.06 |
| EV to Sales | 7.55 | 2.07 | 3.42 | 2.17 | 1.13 |
| EV to Free Cash Flow | -71.68 | -20.07 | -21.11 | -21.24 | -17.64 |
| EV to Operating Cash Flow | -72.48 | -21.79 | -21.72 | -21.68 | -22.73 |
| Tangible Book Value Per Share | 19.39 | 12.86 | 16.19 | 13.99 | 16.33 |
| Shareholders’ Equity Per Share | 19.35 | 12.52 | 15.81 | 13.57 | 15.88 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Revenue Per Share | 6.42 | 14.34 | 13.53 | 16.26 | 18.05 |
| Net Income Per Share | -0.92 | -1.49 | -1.69 | -2.28 | -2.66 |
| Tax Burden | 0.99 | 0.98 | 0.97 | 0.97 | 0.99 |
| Interest Burden | 0.85 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.06 | 0.04 | 0.05 | 0.04 | 0.05 |
| SG&A to Revenue | 0.27 | 0.27 | 0.26 | 0.27 | 0.27 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.72 | 0.90 | 1.22 | 0.69 | 0.33 |
Currency in TWD
